Skip to Content

Press Release

Tiziana Life Science - Distribution Dates: shares and ADRs in Accustem

July 2, 2021 at 7:30 AM EDT
var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document;AKSB=w.AKSB||{},AKSB.q=AKSB.q||[],AKSB.mark=AKSB.mark||function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=AKSB.measure||function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=AKSB.done||function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),{custid:"793678",ustr:"",originlat:"0",clientrtt:"6",ghostip:"",ipv6:false,pct:"10",clientip:"",requestid:"eca71966",region:"42005",protocol:"",blver:14,akM:"dsca",akN:"ae",akTT:"O",akTX:"1",akTI:"eca71966",ai:"501146",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//")}
RNS Number : 0370E
Tiziana Life Sciences PLC
02 July 2021

Tiziana Life Sciences plc

Distribution Dates for shares and ADRs in Accustem Sciences Limited

London, New York, 2 July 2021 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that the Forms 20-F and F-6 filed by Accustem Sciences Limited with the SEC have been declared effective, enabling the completion of the in specie distribution and spin out of Accustem Sciences Limited. These documents can be found at

Times and dates for holders of Tiziana ordinary shares (traded on the London Stock Exchange)

The timetable for the holders of Tiziana ordinary shares (traded on the London Stock Exchange) held in CREST and Certificated form is as follows:

Demerger Record Time:                                                          7:00 a.m. on 30 October 2020

Ex-entitlement date for Accustem Shares:                               2 November 2020

CREST accounts credited with Accustem Shares:                   8 July 2021*

Certificates for Accustem Shares for those shareholders

holding their Tiziana Life Sciences plc in certificated form:      by 18 July 2021

* replacing allocation placeholders currently showing

Times and dates for holders of Tiziana ADSs (traded on the US Nasdaq Market)

The timetable for the holders of Tiziana ADSs (traded on the Nasdaq market) are subject to different corporate action timings and holders of the ADRs should also refer to the notice  published today by JP Morgan, the ADR depositary bank which can be found at

Announcement Tiziana CUSIP: 88875G101

Corporate Action Type:            Spin Off with DR Distribution

Spin Off Issuer Name:             Accustem Sciences Limited

Spin Off DR CUSIP:                00442Y101

DR Distribution Rate:          1 new Accustem DR(s) issued for every 1 existing Tiziana DR held on DR Record Date

Tax Withholding Rate:              n/a

DR Record Date:                     November 6, 2020

DR Payment Date:                   July 14, 2021

DR Issuance and Cancellation Books close Date: October 28, 2020

DR Issuance and Cancellation Books reopen Date: July 19, 2021

Fees: Issuance fee: $nil per DR issued

The Issuer has announced a Spin Off Distribution in the local market. Existing Tiziana DRs will continue to be valid and will not have to be exchanged for new DRs.

For further enquiries:

United Kingdom:

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

+44 (0)20 7495 2379

United States:


Dave Gentry, CEO

RedChip Companies Inc.

1-800-RED-CHIP (733-2447)





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.